首页> Cancer science> High expression of CD44v9 and xCT in chemoresistant hepatocellular carcinoma: Potential targets by sulfasalazine.

High expression of CD44v9 and xCT in chemoresistant hepatocellular carcinoma: Potential targets by sulfasalazine.

导出 OA

翻译打印收藏纠错

第一作者： Fumitaka,Wada

第一单位： Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume, Japan.;Liver Cancer Research Division, Research Center for Innovative Cancer Therapy, Kurume University, Kurume, Japan.

作者： Fumitaka,Wada ^[1] ; Hironori,Koga ^[1] ; Jun,Akiba ^[2] ; Takashi,Niizeki ^[3] ; Hideki,Iwamoto ^[1] ; Yu,Ikezono ^[1] ; Toru,Nakamura ^[1] ; Mitsuhiko,Abe ^[1] ; Atsutaka,Masuda ^[1] ; Takahiko,Sakaue ^[1] ; Toshimitsu,Tanaka ^[1] ; Tatsuyuki,Kakuma ^[4] ; Hirohisa,Yano ^[2] ; Takuji,Torimura ^[1]

作者单位： Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume, Japan.;Liver Cancer Research Division, Research Center for Innovative Cancer Therapy, Kurume University, Kurume, Japan. ^[1] Department of Pathology, Kurume University School of Medicine, Kurume, Japan. ^[2] Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume, Japan. ^[3] Biostatistics Center, Kurume University, Kurume, Japan. ^[4]

关键词 anticancer drug resistance cancer stem cell combinational therapy oxidative stress sphere formation